Unlocking the Genetic Basis of Disease with Manolis Kellis
The Shift Toward Systems Medicine
Understanding human disease has traditionally relied on animal models to understand specific gene functions. However, Manolis Kellis explains that modern science is in the midst of a paradigm shift where human genetics is now driving the basic biology.
• Genetics as a Unified Language: DNA has provided a common language that unifies the study of biology, and genetics is now doing the same for disease, breaking down the artificial walls between traditional medical departments like heart disease and neurology.
• The Complexity of Disease: Most diseases are polygenic and polyfactorial, involving thousands of genetic variants, most of which fall into non-coding regions of the genome. These variants often function as enhancers that affect gene expression across long distances.
The Puzzle-Solving Pipeline
Kellis outlines a rigorous six-step process for tracing the path from a genetic variant to a therapeutic intervention:
- Identify the Tissue: Using epigenomic maps to see where specific gene regulatory elements are active.
- Identify the Causal Variant: Pinpointing the specific nucleotide responsible among co-inherited blocks.
- Determine the Regulatory Motif: Finding the DNA word disrupted by the variant.
- Identify the Regulator: Determining which protein no longer binds to the motif.
- Find the Target Gene: Using physical genomic folding or experimental perturbation to link the variant to its ultimate target.
- Biological Mechanism: Understanding the cellular process, such as lipogenesis or thermogenesis in obesity, to create targeted therapeutics.
"Understanding the biological mechanisms leading to disease is extremely important in being able to intervene."
Future Frontiers: Robotics, CRISPR, and Single-Cell Sequencing
The ability to solve these puzzles has accelerated due to groundbreaking technologies:
• CRISPR-Cas9: Labeled by Kellis as "genome vandalism" followed by precise cellular repair, it allows for the manipulation of specific genomic loci.
• Massively Parallel Reporter Assays (MPRAs): Instead of one experiment at a time, researchers can now test 10,000 to 7 million genetic hypotheses simultaneously.
• Single-Cell Sequencing: Allows scientists to view the brain—or any organ—at a granular, cell-type-specific level, revealing the diversity of cells like microglia and how they contribute to neurodegenerative disorders like Alzheimer's.
By leveraging AI and these high-throughput methods, we are moving toward a systems medicine approach that considers the full context of a human being's genetics, lifestyle, and unique somatic variations.